c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Merck KGaA therapy for rare tumor approved in the U.S.
Seeking Alpha | Nov 11, 2026 7:46 AM EST
Read original article